Approximately 33 percent of all patients currently eligible to receive lipid-lowering medication (statins) are not taking their medication, recent research published in the Journal of the American College of Cardiology suggests. The same study also showed that one every one in five patients would undergo unnecessary LDL retesting. Specific guidelines dictate whether patients fulfill the … [Read more...]
Hypertension Medication Lowers ALS Risk
A recent study suggests that there is a connection between angiotensin-converting enzyme inhibitor use and a lower risk of developing amyotrophic lateral sclerosis. This type of antihypertensive medication is widely used in the treatment of cardiovascular disease. Researchers compared 729 people diagnosed with ALS to 14,580 people without the condition and concluded that individuals who had … [Read more...]